Life sciences consulting firms support organisations across the broader life sciences ecosystem — including pharmaceutical, biotechnology, medical device, and diagnostics companies — in navigating the scientific, commercial, and regulatory challenges of bringing innovative therapies and technologies to market. These engagements require deep understanding of therapeutic areas, scientific landscapes, stakeholder networks, and evolving healthcare systems. JoveWhizz provides the specialised market research that enables life sciences consultants to assess market opportunities, evaluate clinical trial feasibility, map stakeholder relationships, and build the evidence base for market access and commercial success.
Whether your engagement involves assessing a therapeutic area market, evaluating clinical trial feasibility, mapping key stakeholders, or conducting health economics and outcomes research, JoveWhizz delivers the rigorous, scientifically-informed research that life sciences consulting demands. Our expertise across the full life sciences spectrum — from early-stage research through to commercialisation — makes us a trusted partner for life sciences consulting firms worldwide.
The life sciences industry operates at the intersection of cutting-edge science, stringent regulation, and commercial reality. Consulting engagements in this sector must navigate complex scientific landscapes, evolving regulatory frameworks, and demanding healthcare economics — all while developing strategies that deliver both improved patient outcomes and commercial returns. Market research provides the evidence base that makes this possible, translating scientific understanding into commercial insight and helping consultants develop strategies that are both scientifically sound and commercially viable.
Without specialised life sciences market research, consulting recommendations risk being disconnected from the realities of clinical practice, regulatory requirements, and healthcare system dynamics. Research helps consultants understand the competitive landscape of therapeutic development, assess the feasibility and desirability of clinical trials, identify and engage with key stakeholders across the healthcare ecosystem, and build the health economic evidence that increasingly determines market access. For life sciences consultants, research is the bridge between scientific possibility and commercial reality.
Therapeutic area market assessment provides a comprehensive understanding of the commercial opportunity within a specific disease area. We conduct assessments that include epidemiology-based patient population sizing, current and future treatment landscape analysis, pipeline assessment of competing therapies in development, and identification of unmet medical needs. Our research combines secondary analysis of published literature, clinical trial data, and epidemiological sources with primary research conducted with treating physicians, key opinion leaders, and patient advocacy groups. The assessment provides consultants with a clear picture of market size, growth trajectory, competitive dynamics, and opportunity areas for new therapies or diagnostics.
Clinical trials are among the most expensive and time-critical activities in life sciences product development. We conduct clinical trial feasibility research that evaluates the practical, operational, and strategic factors affecting trial success. Our research assesses patient availability and recruitment potential in different geographies, evaluates the competitive landscape for clinical trial sites and investigators, and examines regulatory and ethical considerations that may affect trial design and execution. We conduct primary research with clinical investigators, site coordinators, and patient advocacy groups to understand barriers to enrolment and identify strategies for accelerating patient recruitment. The insights enable consultants to recommend trial designs and site selections that minimise risk and accelerate development timelines.
The life sciences ecosystem includes a complex network of stakeholders — physicians, patients, payers, regulators, policymakers, advocacy groups, and investors — whose influence and interests must be understood for effective strategy development. We conduct stakeholder mapping that identifies key stakeholders in a specific therapeutic area or market, analyses their influence, interests, and relationships, and provides guidance on engagement strategies. Our stakeholder mapping combines desk research with primary interviews with stakeholders and industry experts to build a detailed picture of the stakeholder landscape and the dynamics that shape it. This research is essential for consultants developing market access strategies, advocacy engagement plans, and commercial launch strategies.
Health Economics and Outcomes Research is increasingly central to life sciences strategy as payers demand evidence of value for money. We conduct HEOR research that includes burden of illness studies, cost-effectiveness analysis, budget impact modelling, patient-reported outcomes research, and quality of life assessment. Our research supports consultants in building the evidence base for market access submissions, developing value dossiers, and designing real-world evidence studies. We combine expertise in health economics methodologies with understanding of payer evidence requirements across different markets, delivering HEOR research that meets the rigorous standards of health technology assessment bodies worldwide.
JoveWhizz brings deep domain expertise in life sciences research, with a team that combines market research methodology with understanding of the scientific, clinical, regulatory, and commercial dimensions of the life sciences industry. We have supported life sciences consulting engagements across pharmaceutical, biotechnology, medical device, and diagnostics sectors, and across a wide range of therapeutic areas. Our research is conducted with the scientific rigour, regulatory compliance, and confidentiality standards that the life sciences industry demands. We understand the specific research requirements of life sciences consulting — from early-stage pipeline assessment through clinical development and commercialisation — and deliver insights that consultants can present with confidence to their clients.
What is a therapeutic area market assessment?
A therapeutic area market assessment provides a comprehensive view of the commercial opportunity within a specific disease area. It includes epidemiological analysis of patient populations, detailed mapping of the current treatment landscape and competitive pipeline, assessment of unmet medical needs, and forecasting of market evolution. The assessment draws on secondary research from published literature, clinical trial data, and epidemiology sources, combined with primary research with physicians, key opinion leaders, and patient advocates.
How do you assess clinical trial feasibility?
Clinical trial feasibility assessment evaluates whether a clinical trial can be successfully executed in a specific geographic location or set of sites. We assess patient availability based on epidemiology and treatment rates, evaluate site and investigator capabilities and interest through primary research, analyse the competitive environment for patient enrolment, and consider regulatory and ethical factors. The assessment provides recommendations on trial design, site selection, and recruitment strategies to minimise risk and accelerate timelines.
What is stakeholder mapping in life sciences?
Stakeholder mapping identifies and analyses the key individuals and organisations that influence the success of a life sciences product or strategy. This includes physicians, patients, payers, regulators, policymakers, advocacy groups, investors, and industry partners. We map their level of influence, their interests and positions, their relationships with other stakeholders, and the dynamics that shape their decisions. The stakeholder map provides a strategic framework for engagement, communication, and advocacy planning.
What is the role of HEOR in life sciences consulting?
Health Economics and Outcomes Research provides the evidence that demonstrates the value of a therapy or technology relative to its cost. This evidence is increasingly required by payers for reimbursement decisions, by clinicians for treatment guideline recommendations, and by regulators for labelling claims. HEOR research includes burden of illness studies, cost-effectiveness analysis, budget impact models, patient-reported outcomes, and real-world evidence studies. For life sciences consultants, HEOR is a critical component of market access and commercialisation strategy.
How do you conduct key opinion leader identification and profiling?
Key opinion leader identification combines desk research to identify potential KOLs based on publication record, clinical trial involvement, and conference presentations, with primary research through peer nomination surveys and expert interviews. We profile KOLs on dimensions including scientific expertise, clinical influence, research activity, advisory board involvement, and relationships with pharmaceutical and medical device companies. The resulting KOL maps help consultants identify the most influential stakeholders for advisory boards, clinical trial leadership, and advocacy engagement.
Planning a life sciences consulting engagement that requires market research? Contact JoveWhizz to discuss how our research capabilities can support your project. We deliver the data and insights that underpin confident life sciences consulting recommendations across therapeutic areas and markets worldwide.
Contact Us